Cargando…

Early-phase clinical trials in a pandemic: learning from the response to COVID-19

Detalles Bibliográficos
Autores principales:	Horsley, Alex, Brightling, Chris, Davies, Jane, Djukanovic, Ratko, Heaney, Liam G, Hussell, Tracy, Marciniak, Stefan J, McGarvey, Lorcan, Porter, Joanna C, Wilkinson, Thomas, Ho, Ling-Pei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191862/ https://www.ncbi.nlm.nih.gov/pubmed/35709826 http://dx.doi.org/10.1016/S2213-2600(22)00062-5

Ejemplares similares

Large scale clinical trials: lessons from the COVID-19 pandemic
por: Horsley, Alex R, et al.
Publicado: (2022)

Objective and Subjective Measurement of Cough in Asthma: A Systematic Review of the Literature
por: Holmes, Joshua, et al.
Publicado: (2022)

Adverse perception of cough in patients with severe asthma: a discrete choice experiment
por: Holmes, Joshua, et al.
Publicado: (2023)

An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma
por: Holmes, Joshua, et al.
Publicado: (2022)

Prevalence of psychomorbidity among patients with chronic cough
por: McGarvey, Lorcan PA, et al.
Publicado: (2006)

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
por: Feldmann, Marc, et al.
Publicado: (2020)

Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough
por: Mazzone, Stuart B., et al.
Publicado: (2020)

Recent progress in the management of chronic cough
por: Song, Woo-Jung, et al.
Publicado: (2020)

Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index
por: McDowell, P. Jane, et al.
Publicado: (2022)

Pathological disease in the lung periphery after acute COVID-19
por: Siddiqui, Salman, et al.
Publicado: (2021)

Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma
por: Couillard, Simon, et al.
Publicado: (2021)

Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
por: Brightling, Christopher E, et al.
Publicado: (2022)

COUGH: consolidating a mature field for the next 5 years
por: Chung, Kian Fan, et al.
Publicado: (2011)

Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease: US and EU Perspectives
por: van Haarst, Aernout, et al.
Publicado: (2019)

Chronic cough: new insights and future prospects
por: Morice, Alyn, et al.
Publicado: (2021)

Biomarker-based corticosteroid adjustment in severe asthma: a modified Delphi consensus
por: Gallagher, Nicola E., et al.
Publicado: (2018)

Advancing Understanding of Mechanisms of Severe Asthma and Drug Effects Using Transcriptomics
por: Djukanović, Ratko
Publicado: (2019)

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
por: McGarvey, Lorcan, et al.
Publicado: (2016)

From bench to bedside: The role of cough hypersensitivity in chronic cough
por: Drake, Matthew G., et al.
Publicado: (2023)

Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial
por: Dushianthan, Ahilanandan, et al.
Publicado: (2020)

Clinical Research Fellow
por: Addy, Charlotte, et al.
Publicado: (2019)

The relationship between the Leicester cough questionnaire, eosinophilic airway inflammation and asthma patient related outcomes in severe adult asthma
por: Natarajan, Sushiladevi, et al.
Publicado: (2017)

Reincarnations of the phase separation problem
por: Dong, Ruo-Yu, et al.
Publicado: (2021)

Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trial
por: Stern, Edward P., et al.
Publicado: (2022)

The everlasting hunt for new ice phases
por: Hansen, Thomas C.
Publicado: (2021)

Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study
por: Monk, Phillip D., et al.
Publicado: (2023)

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry
por: Heaney, Liam G, et al.
Publicado: (2010)

A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)
por: Dushianthan, Ahilanandan, et al.
Publicado: (2023)

Open questions on liquid–liquid phase separation
por: Spruijt, Evan
Publicado: (2023)

Clean Care is Safer Care: a worldwide priority
por: Pittet, Didier, et al.
Publicado: (2005)

Acute Respiratory Distress Syndrome Caused by Mycoplasma Pneumoniae Diagnosed by Polymerase Chain Reaction
por: Yew, Peter, et al.
Publicado: (2012)

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
por: Monk, Phillip D, et al.
Publicado: (2021)

Subcutaneous interferon beta-1a in COVID-19: raking the ashes of an intervention trial
por: Wilkinson, Tom
Publicado: (2021)

Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry
por: Sweeney, Joan, et al.
Publicado: (2012)

Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD
por: Andreas, Stefan, et al.
Publicado: (2020)

Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study
por: Morice, Alyn, et al.
Publicado: (2021)

Mandatory polio vaccination for travellers: protecting global public health
por: Rutter, Paul D, et al.
Publicado: (2014)

Phasing out monkeypox: mpox is the new name for an old disease
por: Damaso, Clarissa R.
Publicado: (2022)

Open questions on the interaction dynamics of molecules and clusters in the gas phase
por: Gatchell, Michael, et al.
Publicado: (2022)

Innovations to improve the efficiency of phase II IBD clinical trials
por: Noor, Nurulamin M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2ckjcmkn3pkp29cr49ut4ish4a